Figures & data
Table 1. Patient population and tumour characteristics.
Figure 1. MWA in a 56-year-old man with intrahepatic recurrence of HCC adjacent to the diaphragm. (A) CE-MRI imaging obtained before ablation showed a hyper-enhanced area in segment II (long arrow). (B) The CEUS revealed a hyper-enhanced nodule in the left lobe. (C) Adjuvant 2.5 mL of ethanol was injected into the tumour edge adjacent to the diaphragm. (D) In the process of MWA, the hyper-echo completely covered the tumour. (E) CEUS obtained 3 days after ablation showed no enhancement (long arrow). (F) CE-MRI imaging obtained 4 months after ablation displayed no enhancement in the ablation zone (long arrow).
![Figure 1. MWA in a 56-year-old man with intrahepatic recurrence of HCC adjacent to the diaphragm. (A) CE-MRI imaging obtained before ablation showed a hyper-enhanced area in segment II (long arrow). (B) The CEUS revealed a hyper-enhanced nodule in the left lobe. (C) Adjuvant 2.5 mL of ethanol was injected into the tumour edge adjacent to the diaphragm. (D) In the process of MWA, the hyper-echo completely covered the tumour. (E) CEUS obtained 3 days after ablation showed no enhancement (long arrow). (F) CE-MRI imaging obtained 4 months after ablation displayed no enhancement in the ablation zone (long arrow).](/cms/asset/345e2d8b-2798-4d89-b7dc-d9a012e968a9/ihyt_a_1091953_f0001_c.jpg)